Literature DB >> 28206903

Prevalence, conservation and functional analysis of Yersinia and Escherichia CRISPR regions in clinical Pseudomonas aeruginosa isolates.

K C Cady1, A S White1, J H Hammond1, M D Abendroth1, R S G Karthikeyan2, P Lalitha2, M E Zegans3, G A O'Toole1.   

Abstract

Here, we report the characterization of 122 Pseudomonas aeruginosa clinical isolates from three distinct geographical locations: Dartmouth Hitchcock Medical Center in New Hampshire, USA, the Charles T. Campbell Eye Microbiology Lab at the University of Pittsburgh Medical Center, USA, and the Aravind Eye Hospital in Madurai, India. We identified and located clustered regularly interspaced short palindromic repeats (CRISPR) in 45/122 clinical isolates and sequenced these CRISPR, finding that Yersinia subtype CRISPR regions (33 %) were more prevalent than the Escherichia CRISPR region subtype (6 %) in these P. aeruginosa clinical isolates. Further, we observed 132 unique spacers from these 45 CRISPR that are 100 % identical to prophages or sequenced temperate bacteriophage capable of becoming prophages. Most intriguingly, all of these 132 viral spacers matched to temperate bacteriophage/prophages capable of inserting into the host chromosome, but not to extrachromosomally replicating lytic P. aeruginosa bacteriophage. We next assessed the ability of the more prevalent Yersinia subtype CRISPR regions to mediate resistance to bacteriophage infection or lysogeny by deleting the entire CRISPR region from sequenced strain UCBPP-PA14 and six clinical isolates. We found no change in CRISPR-mediated resistance to bacteriophage infection or lysogeny rate even for CRISPR with spacers 100 % identical to a region of the infecting bacteriophage. Lastly, to show these CRISPR and cas genes were expressed and functional, we demonstrated production of small CRISPR RNAs. This work provides both the first examination to our knowledge of CRISPR regions within clinical P. aeruginosa isolates and a collection of defined CRISPR-positive and -negative strains for further CRISPR and cas gene studies.

Entities:  

Year:  2011        PMID: 28206903     DOI: 10.1099/mic.0.045732-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  3 in total

Review 1.  CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens.

Authors:  Ujjayani Saha; Rashmi Gondi; Amrita Patil; Sunil D Saroj
Journal:  Mol Biotechnol       Date:  2022-08-08       Impact factor: 2.860

2.  Novel PCR detection of CRISPR/Cas systems in Pseudomonas aeruginosa and its correlation with antibiotic resistance.

Authors:  Mai Soliman; Heba Shehta Said; Mohammed El-Mowafy; Rasha Barwa
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-30       Impact factor: 5.560

3.  Repurposing type I-F CRISPR-Cas system as a transcriptional activation tool in human cells.

Authors:  Yuxi Chen; Jiaqi Liu; Shengyao Zhi; Qi Zheng; Wenbin Ma; Junjiu Huang; Yizhi Liu; Dan Liu; Puping Liang; Zhou Songyang
Journal:  Nat Commun       Date:  2020-06-19       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.